Advertisements



Novartis Delivers In Breast Cancer Study, Could Lead To A Major Battle With Competitors

Novartis Delivers In Breast Cancer Study, Could Lead To A Major Battle With Competitors.....»»

Category: topSource: seekingalphaOct 9th, 2019

Merck"s Keytruda Shines In Breast Cancer Study, Could Possibly Lead To Accelerated Approval

Merck"s Keytruda Shines In Breast Cancer Study, Could Possibly Lead To Accelerated Approval.....»»

Category: topSource: seekingalphaOct 2nd, 2019

The Agenda: A major grant for Roswell, fiscal tightening for Niagara Falls and a rainy Wednesday

MORNING LEAD Roswell Park Comprehensive Cancer Center will move ahead with a three-part strategy to treat advanced cancers with help from a federal grant. The four-year $6.42 million Breakthrough Award comes from the U.S. Department of Defense’s.....»»

Category: topSource: bizjournalsOct 2nd, 2019

Nektar breast cancer data "promising," warrants more study, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 26th, 2019

AI is improving the accuracy of breast cancer detection

As artificial intelligence is poised to change a number of industries, a new study shows promise of its use in more accurately detecting certain types of breast cancer.  Researchers at the University of California-Los Angeles have developed an A.....»»

Category: topSource: bizjournalsAug 14th, 2019

Xoma"s gevokizumab used to dose first patient in cancer study by Novartis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

Novartis Gets FDA Nod for Breast Cancer Drug & Gene Therapy

Zacks.....»»

Category: topSource: redinewsMay 27th, 2019

FDA approves Novartis" Piqray for breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2019

Novartis gets FDA nod for advanced breast-cancer treatment

Novartis AG said late Friday the U.S. Food and Drug Administration has approved one of its treatments for a type of advanced breast cancer afflicting patients carrying a gene.....»»

Category: topSource: marketwatchMay 24th, 2019

OncoSec reports interim data from Keynote-890 study of breast cancer combination

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic breast cancer who have previously been treated with........»»

Category: blogSource: 247wallstMay 16th, 2019

Myriad announces findings from EndoPredict study in early stage breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2019

At-home genetic kits don"t reveal all breast cancer risks

Millions of people have bought into the mail-in DNA testing craze, but a new study indicates consumers should be aware of the limitations of the health tests offered.  Those who expect 23andMe to detect most breast cancer risks are being cautioned.....»»

Category: topSource: bizjournalsApr 19th, 2019

New brain tumor treatments being investigated at UAB

UAB Medicine is leading an initiative to study brain tumors in dogs, which may lead to further investigations to treat humans. The five-year, $2.6 million project project is funded by the Comparative Oncology Program of the National Cancer Instit.....»»

Category: topSource: bizjournalsApr 18th, 2018

Celldex"s Phase II Breast Cancer Study Fails, Shares Plunge

Celldex Therapeutics' (CLDX) glembatumumab vedotin fails to meet primary endpoint in phase IIb METRIC study in metastat.....»»

Category: smallbizSource: nytApr 17th, 2018

Why Celldex Therapeutics Is Getting Crushed

Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study......»»

Category: blogSource: 247wallstApr 16th, 2018

No Harm in Reducing Use of Roche Drug for Breast Cancer, Study Says

Treating breast-cancer patients with an expensive Roche drug for six months instead of 12 reduced heart-related side effects without sacrificing effectiveness, a new study found......»»

Category: smallbizSource: wsjMay 16th, 2018

Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests......»»

Category: topSource: foxnewsMay 16th, 2018

Most Common Childhood Cancer Is Likely Caused by Lack of Exposure to Infections, Major Study Finds

The findings are the product of three decades of research......»»

Category: topSource: newsweekMay 22nd, 2018

Cutting out bacon and booze could reduce your risk of cancer by up to 40%, according to a major new study of over 50 million people

Lukasz Engel / Shutterstock The World Cancer Research Fund (WCRF) has unveiled a 10-point plan to cut your risk of getting cancer.....»»

Category: topSource: businessinsiderMay 24th, 2018

A common ingredient in toothpaste may lead to higher rates of cancer and inflammation, according to a new study

Toothpaste is one of many household products we use daily that containes the antimicrobial chemical triclosan.  A recent study suggests that this chemical may aggravate inflammation in .....»»

Category: topSource: businessinsiderJun 1st, 2018